CompuGroup Medical AG Second Quarter Results 2015

CompuGroup Medical AGCompuGroup Medical AG today presented the financial report for the second quarter of 2015. The company, one of the leading global providers of eHealth solutions, achieved revenue of EUR 138 million, compared to EUR 126 million in the second quarter 2014. This represents an increase of 9 percent, of which 4 percent is organic growth.

With this result, the good start to the year continues for CompuGroup Medical. There is broad-based progress in most business areas and a pronounced group-wide margin increase as the most notable improvement. Consolidated EBITDA in the second quarter amounted to EUR 30 million compared to EUR 23 million in 2014. The corresponding operating margin was well above 21 percent compared to 18 percent in 2014.

The hospital segment has developed particularly well in the period and it is the market in Poland that contributes with a high organic growth rate driven by a larger CGM participation in the on-going national e-health project there. Order intake has also improved in the hospital area and CGM was in June awarded the contract for the implementation and delivery of a comprehensive new hospital information system for five regional hospitals in Vorarlberg, Austria.

Parallel to the positive financial and operational development, CGM continues its prominent role in the largest on-going eHealth initiative in Germany - the Telematics Infrastructure and Electronic Health Card (eGK) pilot project. At the Hauptstadtkongress in Berlin in June, CGM showed live for the second time the insured master data update based on the eGK. With an official real-life demonstration of all required hardware and software components fully functional, CGM shows its readiness for a successful rollout to test the Telematics Infrastructure in in the pilot region North/West.

Frank Gotthardt, CEO and Chairman of the Board of CompuGroup Medical AG, stated: "The numbers we deliver for the second quarter reaffirm our commitment to improve margins and profitability for the Group. While doing this, we also drive the electronic health card project in Germany forward with full commitment. A worthy finish to the quarter came with the our new hospital contract in Austria which shows the increasing leverage we are getting in the market from our long-time investment in our next generation G3 product platform."

CompuGroup Medical reaffirms the full year 2015 guidance presented in the 2014 Annual Report. Including revenue from recent acquisitions, Group revenue is expected to be in the range of EUR 549 million to EUR 559 million and operating income (EBITDA) is expected to be in the range of EUR 115 million to EUR 125 million.

About CompuGroup Medical AG
CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of more than EUR 500 million, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of approximately 400,000 doctors, dentists, pharmacists and other service providers in inpatient and outpatient facilities. With locations in 19 countries and products in more than 40 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. Approximately 4,200 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI, Health, and Health Care Today and To…

Artificial intelligence (AI) carries promise and uncertainty for clinicians, patients, and health systems. This JAMA Summit Report presents expert perspectives on the opportunities, risks, and challenges of AI in health...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...

New AI Tool Makes Medical Imaging Proces…

When doctors analyze a medical scan of an organ or area in the body, each part of the image has to be assigned an anatomical label. If the brain is...